The CDTI Innovación invests, together with ORZA GESTIÓN Y TENENCIA DE PATRIMONIOS, AIE and UN R+D+i TECHNOLOGY TRANSFER FCR, in EVERSENS, S.L.

The CDTI innovation, through its programme Innvierte ORZA, together with MANAGEMENT AND POSSESSION OF assets, IEA and r + D + i TECHNOLOGY TRANSFER RCF, have reached an agreement with EVERSENS, company dedicated to the design, technological development, manufacture and marketing of analysis solutions breathing for the detection of biomarkers exhalados, to finance the company through a participatory loan capitalizable

Eversens_Coinversión
The input committed by the CDTI innovation is €250,000

everSens leads in the design, development and manufacture of innovative solutions for the analysis of biomarkers exhalados. Your developments provide Useful information for non-invasive diagnosis and monitoring of various illnesses, for improving the quality of life of millions of people around the world.



His first product marketed, evernoa, allows a more precise diagnostic and therapeutic better selection in asthmatic patients, as it provides information on the underlying inflammation of the air. This device is already available in more than 22 countries, where the company has sold more than 150,000 evidence.



Every day, 1 million people suffer from respiratory attack in the world and the 9000 die. Eversens evernoa mini has developed a revolutionary device that identifies, objectively, to patients who are at risk of an attack. This device allows, for the first time, monitor the inflammation of a regular basis in the home of the mini pacientes. evernoa may also be used in primary health care for the diagnosis and 80 per cent of asthmatic patients treated at this level.



Backed by a global team and highly skilled staff, as well as for opinion leaders in the field respiratory, Eversens fund to continue To grow in international markets, including the united states, and to continue, so, leading the analysis of breathing.

 

ORZA



ORZA MANAGEMENT AND POSSESSION OF assets, IEA is a direct investment, belonging to theEPSV GeroaandElkarkidetza, which supports business network in the basque country and navarre. It Is a partner with permanent beyond the date of venture Capital entities that can finance successive growth stages of a society.

 

UNIDI



A r + D + i Technology Transfer f.c.r. is a venture capital fund is promoted in 2016 and managed by Key Capital in collaboration with the university of Navarra to invest in projects Deeptech in initial stages, especially preseed and seed. During these years he has done more than 15 investments, having conducted the first divestments.



The fund falls within the overall strategy of Capital, as Key manager of Venture Capital of national leadership in the area of technology transfer and investment in knowledge generated in research environments, managing at present, there are approximately eur 100 million in this area through different venture capital funds.
 

CDTI Innovation

The CDTI innovation is the agency of the ministry of science and innovation that supports innovation based on knowledge, advice and providing public funding for innovation through subsidies or aid partly refundable for innovation and managing public procurement, pre-commercial.



Additionally, through the initiative Innvierte Sustainable Economy, supports and facilitates the capitalization of technology companies. To date, the CDTI, through Innvierte, has committed more than 390 M €in 20 investment vehicles that have invested in more than 240 companies, and through its joint investment line directly committed an amount in excess of 338 M €in at least 135 enterprises. ”



The CDTI Innovation also facilitates the internationalization of business projects of r & D and innovation of spanish companies and entities and manages the participation of spanish companies in international r & D, Horizon and Eureka, Europe and in industries of science and space.

The centre for technological development and innovation, E.P.E. (CDTI) is a public entity under the ministry of Science and innovation.
 

More information:

Office of the press

prensa@cdti.es

91-581.55.00
 

On The Internet

Website:www.cdti.es

In Linkedin:https :// www.linkedin.com/company/29815

X:https :// twitter.com/CDTI _ innovation

On Youtube:https :// www.youtube.com/user/CDTIoficial